Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma

Virchows Archiv

Volumn 442, Issue 3, 2003, Pages 284-293

  Steimle Grauer, Susanne Annette ^a   Tinguely, Marianne ^a   Seada, Laila ^a   Fellbaum, Christian ^a   Hansmann, Martin Leo ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

BOB.1 OBF1; BSAP Pax5; Hodgkin lymphoma; MUM1 IRF4; Oct2; Transcription factors

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BOB 1; TRANSCRIPTION FACTOR BSAP; TRANSCRIPTION FACTOR MUM1; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037354540     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-002-0735-5     Document Type: Article

References (52)

1. Anagnostopoulos I, Hansmann ML, Franssila K, Harris M, Harris NL, Jaffe ES, Han J, van Krieken JM, Poppema S, Marafioti T, Franklin J, Sextro M, Diehl V, Stein H (2000) European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96:1889-1899
2. Ashton-Key M, Thorpe PA, Allen JP, Isaacson PG (1995) Follicular Hodgkin's disease. Am J Surg Pathol 19:1294-1299
3. Barberis A, Widenhorn K, Vitelli L, Busslinger M (1990) A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. Genes Dev 4:849-859
4. Brass AL, Zhu AQ, Singh H (1999) Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J 18:977-991
5. Bräuninger A, Küppers R, Strickler JG, Wacker HH, Rajewsky K, Hansmann ML (1997) Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A 94:9337-9342
6. Bräuninger A, Hansmann ML, Strickler JG, Dummer R, Burg G, Rajewsky K, Küppers R (1999) Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med 340:1239-1247
7. Bräuninger A, Yang W, Wacker HH, Rajewsky K, Küppers R, Hansmann ML (2001) B-cell development in progressively transformed germinal centers: similarities and differences compared with classical germinal centers and lymphocyte-predominant Hodgkin disease. Blood 97:714-719
8. Diehl V, Sextro M, Franklin J, Hansmann ML, Harris N, Jaffe E, Poppema S, Harris M, Franssila K, van Krieken J, Marafioti T, Anagnostopoulos I, Stein H (1999) Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol 17:776-783
9. Falini B, Fizzotti M, Pucciarini A, Bigerna B, Marafioti T, Gambacorta M, Pacini R, Alunni C, Natali-Tanci L, Ugolini B, Sebastiani C, Cattoretti G, Pileri S, Dalla-Favera R, Stein H (2000) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 95:2084-2092
10. Foss HD, Reusch R, Demel G, Lenz G, Anagnostopoulos I, Hummel M, Stein H (1999) Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood 94:3108-3113
11. Gstaiger M, Knoepfel L, Georgiev O, Schaffner W, Hovens CM (1995) A B-cell coactivator of octamer-binding transcription factors. Nature 373:360-362
12. Hansmann ML, Fellbaum C, Hui PK, Moubayed P (1990) Progressive transformation of germinal centers with and without association to Hodgkin's disease. Am J Clin Pathol 93:219-226
13. Hansmann ML, Weiss LM, Stein H, Harris NL, Jaffe ES (1999) Pathology of lymphocyte predominance Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM (eds) Hodgkin's disease. Lippincott Williams & Wilkins, Philadelphia, pp 169-180
14. Harada H, Taniguchi T, Tanaka N (1998) The role of interferon regulatory factors in the interferon system and cell growth control. Biochimie 80:641-650
15. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LW, Rosenfeld MG (1989) Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 340:35-41
16. Hess J, Nielsen PJ, Fischer KD, Bujard H, Wirth T (2001) The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol Cell Biol 21:1531-1539
17. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RS, Dalla-Favera R (1997) Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 17:226-230
18. Jackson (1937) Classification and prognosis of Hodgkin's disease and allied disorders. Surg Gynecol Obstet 64:465
19. Kanzler H, Küppers R, Hansmann ML, Rajewsky K (1996) Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 184:1495-1505
20. Kim U, Qin XF, Gong S, Stevens S, Luo Y, Nussenzweig M, Roeder RG (1996) The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature 383:542-547
21. Krenacs L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES, Raffeld M (1998) Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. Blood 92:1308-1316
22. Küppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann ML (1994) Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A 91:10962-10966
23. Küppers R, Rajewsky K, Bräuninger A, Hansmann ML (1998) L&H cells in lymphocyte-predominant Hodgkin's disease. N Engl J Med 338:763-765
24. Laumen H, Nielsen PJ, Wirth T (2000) The BOB.1 / OBF.1 coactivator is essential for octamer-dependent transcription in B cells. Eur J Immunol 30:458-469
25. Luo Y, Roeder RG (1995) Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol Cell Biol 15:4115-4124
26. Marafioti T, Hummel M, Anagnostopoulos I, Foss HD, Falini B, Delsol G, Isaacson PG, Pileri S, Stein H (1997) Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 337:453-458
27. Marafioti T, Hummel M, Foss HD, Laumen H, Korbjuhn P, Anagnostopoulos I, Lammert H, Demel G, Theil J, Wirth T, Stein H (2000) Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 95:1443-1450
28. Mittrucker HW, Matsuyama T, Grossman A, Kundig TM, Potter J, Shahinian A, Wakeham A, Patterson B, Ohashi PS, Mak TW (1997) Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275:540-543
29. Müschen M, Rajewsky K, Bräuninger A, Baur AS, Oudejans JJ, Roers A, Hansmann ML, Küppers R (2000) Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J Exp Med 191:387-394
30. Nelson N, Kanno Y, Hong C, Contursi C, Fujita T, Fowlkes BJ, O'Connell E, Hu-Li J, Paul WE, Jankovic D, Sher AF, Coligan JE, Thornton A, Appella E, Yang Y, Ozato K (1996) Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation. J Immunol 156:3711-3720
31. Nguyen PL, Ferry JA, Harris NL (1999) Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's disease: a comparative immunohistochemical study. Am J Surg Pathol 23:27-33
32. Nutt SL, Thevenin C, Busslinger M (1997) Essential functions of Pax-5 (BSAP) in pro-B cell development. Immunobiology 198:227-235
33. Nutt SL, Urbanek P, Rolink A, Busslinger M (1997) Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev 11:476-491
34. Nutt SL, Morrison AM, Dorfler P, Rolink A, Busslinger M (1998) Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J 17:2319-2333
35. Nutt SL, Heavey B, Rolink AG, Busslinger M (1999) Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401:556-562
36. Nutt SL, Eberhard D, Horcher M, Rolink AG, Busslinger M (2001) Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis. Int Rev Immunol 20:65-82
37. Re D, Müschen M, Ahmadi T, Wickenhauser C, Staratschek-Jox A, Holtick U, Diehl V, Wolf J (2001) Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. Cancer Res 61:2080-2084
38. Rolink AG, Nutt SL, Melchers F, Busslinger M (1999) Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401:603-606
39. Saez AI, Artiga MJ, Sanchez-Beato M, Sanchez-Verde L, Garcia JF, Camacho FI, Franco R, Piris MA (2002) Analysis of Octamer-Binding Transcription Factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in Lymphomas. Mod Pathol 15:211-220
40. Scheidereit C, Heguy A, Roeder RG (1987) Identification and purification of a human lymphoid-specific octamer-binding protein (OTF-2) that activates transcription of an immunoglobulin promoter in vitro. Cell 51:783-793
41. Schmid C, Pan L, Diss T, Isaacson PG (1991) Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Am J Pathol 139:701-707
42. Schubart DB, Rolink A, Kosco-Vilbois MH, Botteri F, Matthias P (1996) B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature 383:538-542
43. Seitz V, Hummel M, Marafioti T, Anagnostopoulos I, Assaf C, Stein H (2000) Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood 95:3020-3024
44. Singh H, Sen R, Baltimore D, Sharp PA (1986) A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319:154-158
45. Staudt LM, Singh H, Sen R, Wirth T, Sharp PA, Baltimore D (1986) A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature 323:640-643
46. Stein H, Marafioti T, Foss HD, Laumen H, Hummel M, Anagnostopoulos I, Wirth T, Demel G, Falini B (2001) Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 97:496-501
47. Strubin M, Newell JW, Matthias P (1995) OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80:497-506
48. Sturm RA, Das G, Herr W (1988) The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev 2:1582-1599
49. Taniguchi T, Harada H, Lamphier M (1995) Regulation of the interferon system and cell growth by the IRF transcription factors. J Cancer Res Clin Oncol 121:516-520
50. Tsuboi K, Iida S, Inagaki H, Kato M, Hayami Y, Hanamura I, Miura K, Harada S, Kikuchi M, Komatsu H, Banno S, Wakita A, Nakamura S, Eimoto T, Ueda R (2000) MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia 14:449-456
51. Yee AA, Yin P, Siderovski DP, Mak TW, Litchfield DW, Arrowsmith CH (1998) Cooperative interaction between the DNA-binding domains of PU.1 and IRF4. J Mol Biol 279:1075-1083
52. Zukerberg LR, Collins AB, Ferry JA, Harris NL (1991) Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 139:475-483